{"title": "Farma Network", "author": "Giovanny Leon", "url": "http://farmanetwork.blogspot.com/2011/10/", "hostname": "blogspot.com", "description": "Un espacio de encuentro profesional virtual para los colegas de la industria farmaceutica", "sitename": "farmanetwork.blogspot.com", "date": "2012-04-27", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Un espacio de encuentro profesional virtual para los colegas de la industria farmaceutica\n[Las farmac\u00e9uticas navegan en la tormenta perfecta](https://farmanetwork.blogspot.com/2011/10/las-farmaceuticas-navegan-en-la.html?m=0)\nContar con un blockbuster, un medicamento que sea un \u00e9xito de ventas, puede aportar a una farmac\u00e9utica m\u00e1s de 1.000 millones de d\u00f3lares en ingresos al a\u00f1o. Pero cada vez existen menos superventas. Las patentes se caducan y encontrar nuevas mol\u00e9culas que mejoren las existentes es un proceso que absorbe gigantescas y crecientes cantidades de dinero. Y si el entorno no es precisamente favorable, con recortes en gasto sanitario en los pa\u00edses desarrollados, los laboratorios empiezan a sufrir un desgaste que hasta ahora no hab\u00edan vivido.\n\"Es una convulsi\u00f3n formidable. Se ha formado la tormenta perfecta para las farmac\u00e9uticas. Tienen unos costes brutales para desarrollar la I+D y las patentes no siempre garantizan un retorno suficiente. Eso provoca que decaiga la investigaci\u00f3n en algunos campos, como ha pasado por ejemplo con los antibi\u00f3ticos\", explica el vicedecano de Esade y profesor en materia sanitaria Manel Peir\u00f3. De hecho, es muy concluyente con lo que le ocurrir\u00e1 al sector: \"El modelo de negocio actual comienza a tener muchas dificultades para el futuro\".\nNo todo es tan negativo. Al menos de momento, por el lado de los ingresos, el mercado global sanitario y de f\u00e1rmacos sigue creciendo. Seg\u00fan la consultora IMS Health, en 2015, el gasto mundial en medicinas habr\u00e1 alcanzado los 800.000 millones de euros, a un ritmo de incremento anual de entre un 3% y un 6%, algo inferior al 6,2% de los \u00faltimos cinco a\u00f1os.\nEsta firma destaca que la expiraci\u00f3n de patentes en los mercados desarrollados reducir\u00e1 en m\u00e1s de 20 puntos la venta de f\u00e1rmacos de marca, que no ser\u00e1n compensados por las zonas en desarrollo. Pero ser\u00e1n precisamente los pa\u00edses emergentes los que m\u00e1s incrementen su gasto, \"incluso superando el de Alemania, Francia, Italia, Espa\u00f1a y Reino Unido juntos\", se se\u00f1ala en un informe de la consultora.\nPor patolog\u00edas, ser\u00e1 el c\u00e1ncer y la diabetes las que m\u00e1s facturaci\u00f3n consigan (de hecho, el negocio de oncolog\u00eda crecer\u00e1 hasta un 8% anual hasta 2015), aunque enfermedades como la esclerosis y la osteoporosis se llevar\u00e1n los mayores aumentos en el gasto.\n\"Est\u00e1 claro que reforzar la presencia en los mercados emergentes, como China o India, es el gran reto de las farmac\u00e9uticas\", destaca Jordi Ib\u00e1\u00f1ez, socio de Accenture. Una cura para mantener el ritmo de ingresos.\n\"En los pa\u00edses desarrollados, los recortes han llegado para quedarse\", opina Peir\u00f3. \"Lo que no es muy fino es el tijeretazo solo en el gasto farmac\u00e9utico. Sin embargo, los precios sanitarios siguen creciendo. Es el caso espa\u00f1ol, donde hay un problema sanitario, de cultura, no solo de gasto farmac\u00e9utico\", a\u00f1ade.\n\"Recortar en este coste es lo m\u00e1s f\u00e1cil\", confirma Ib\u00e1\u00f1ez, \"pero hay que tener cuidado porque se puede destruir un importante tejido industrial\". Pone como ejemplo a Catalu\u00f1a, \"una regi\u00f3n donde esta industria supone un 8% del PIB y, sin embargo, a la automoci\u00f3n, que supone un 10%, la ponemos entre algodones\".\nAdem\u00e1s de que hacer caja no parece tan sencillo como en a\u00f1os anteriores, los altos costes de la I+D siguen creciendo. Tradicionalmente se ha convenido que desarrollar un f\u00e1rmaco cuesta unos 1.000 millones de d\u00f3lares. \"Lanzar un \u00e9xito como el de Messi cuesta mucho. Por eso, si se cambia el marco legal constantemente, se dificulta la inversi\u00f3n en nuevos productos y las multinacionales pueden llevarse la inversi\u00f3n de un pa\u00eds a otro, un riesgo que puede sufrir Espa\u00f1a\", cree Ib\u00e1\u00f1ez.\nPero adem\u00e1s, alcanzar ese Messi con el que todo laboratorio sue\u00f1a es menos frecuente, ya que las nuevas mol\u00e9culas se dirigen a patolog\u00edas m\u00e1s concretas. El ejemplo m\u00e1s claro es el del c\u00e1ncer. La quimioterapia, aquella bomba at\u00f3mica que arrasa con todo, se sustituye por medicamentos dirigidos a tumores espec\u00edficos con pacientes que previamente se sabe que van a responder correctamente. Es el caso del Herceptin, del laboratorio Roche, para tumores de mama. Significa, por tanto, que hay que lanzar sobre dianas m\u00e1s precisas y cada f\u00e1rmaco se aplica en una poblaci\u00f3n menor.\n\u00bfC\u00f3mo compensar esa circunstancia? Con precios m\u00e1s altos, que las autoridades sanitarias est\u00e1n dispuestas a sufragar si realmente esos tratamientos dirigidos son m\u00e1s efectivos. \"La industria tiene que comprender que debe dejar de vender producto para comenzar a comercializar efectividad\", aclara el socio de Accenture.\nEspecializarse en buscar mol\u00e9culas muy concretas, ha llevado a que el mercado farmac\u00e9utico sea muy din\u00e1mico en fusiones y adquisiciones. \"Seguiremos viendo compras. De hecho, si no ha habido m\u00e1s en los \u00faltimos meses se debe a la dificultad de los bancos para financiar grandes operaciones\", opina el profesor de Esade.\nLas grandes farmas han delegado la investigaci\u00f3n b\u00e1sica de nuevos productos, en gran parte, a peque\u00f1as start-ups -la mayor\u00eda del \u00e1mbito biotecnol\u00f3gico-. Normalmente, el camino es el siguiente: de una universidad surge una patente o una idea a desarrollar, por lo que se crea una peque\u00f1a empresa. Si las primeras fases de la investigaci\u00f3n son prometedoras, la gran farmac\u00e9utica adquiere la licencia del producto o directamente se come al pez peque\u00f1o, con la idea de desarrollar el f\u00e1rmaco en las \u00faltimas fases, las m\u00e1s costosas.\nEsta situaci\u00f3n ha llevado a cientos de peque\u00f1as compras al a\u00f1o en el sector. Aunque tambi\u00e9n se han producido grandes compras, como la de Wyeth por parte de Pfizer o la de la biotecnol\u00f3gica Genzyme por parte de Sanofi. \"Es una huida hacia delante. Si a una grande le expiran patentes, seguir\u00e1 devorando a otras para mantener su facturaci\u00f3n\", cree Ib\u00e1\u00f1ez.\n[El Nobel de Medicina compartido por 3 inmunologos](https://farmanetwork.blogspot.com/2011/10/el-nobel-de-medicina-compartido-por-3.html?m=0)\nLos inmun\u00f3logos estadounidense Bruce A. Beutler, franc\u00e9s Jules A. Hoffmann y canadiense Ralph M. Steinman son los ganadores del Premio Nobel de Medicina 2011, comunic\u00f3 el Instituto Karolinska de Estocolmo.\nEl tr\u00edo de cient\u00edficos compartir\u00e1 el galard\u00f3n por su descripci\u00f3n del sistema inmune humano, inform\u00f3 el instituto, que ha servido para luchar contra enfermedades contagiosas y desarrollar vacunas.\nBeutler y Hoffmann compartir\u00e1n la mitad del premio por el estudio de la inmunidad cong\u00e9nita y Steinman por el descubrimiento de las c\u00e9lulas dendr\u00edticas que activan el sistema inmune.\nEl estadounidense Beutler naci\u00f3 en 1957 en Chicago (EEUU), y ejerce en el instituto de investigaci\u00f3n Scripps de California. Su colega Hoffmann, nacido en Luxemburgo en 1941 y de nacionalidad francesa, es presidente de la Academia Francesa de las Ciencias desde 2007. En tanto, el canadiense Steinman naci\u00f3 en 1943 en Montreal y es profesor en la Universidad Rockefeller de Nueva York.\nLos ganadores del premio, dotado con 10 millones de coronas suecas (1,1 millones de euros), siguen en la n\u00f3mina del m\u00e1s codiciado galard\u00f3n del \u00e1mbito de la medicina al brit\u00e1nico Robert G. Edwards, \"padre\" del primer beb\u00e9 probeta, la brit\u00e1nica Louise Brown (1978). Edwards obtuvo el Nobel en 2010 por sus investigaciones sobre la fecundaci\u00f3n in vitro.\nLa entrega de los Nobel se realizar\u00e1, de acuerdo a la tradici\u00f3n, en dos ceremonias paralelas, en Oslo para el de la Paz y en Estocolmo los restantes, el d\u00eda 10 de diciembre, aniversario de la muerte de Alfred Nobel.\nSuscribirse a:", "language": null, "image": null, "pagetype": null, "links": ["https://farmanetwork.blogspot.com/?m=0", null, "https://farmanetwork.blogspot.com/2011/10/las-farmaceuticas-navegan-en-la.html?m=0", "http://www.toonpool.com/user/496/files/billions_n_billions_320435.jpg", "https://www.blogger.com/profile/05824074357364364632", "https://farmanetwork.blogspot.com/2011/10/las-farmaceuticas-navegan-en-la.html?m=0#comment-form", "https://www.blogger.com/email-post.g?blogID=5620298639202866827&postID=1239102224592869586", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1239102224592869586&target=email", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1239102224592869586&target=blog", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1239102224592869586&target=twitter", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1239102224592869586&target=facebook", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1239102224592869586&target=pinterest", "https://farmanetwork.blogspot.com/search/label/estrategia?m=0", "https://farmanetwork.blogspot.com/search/label/investigaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/tendencias?m=0", null, "https://farmanetwork.blogspot.com/2011/10/el-nobel-de-medicina-compartido-por-3.html?m=0", "http://www.lv7.com.ar/img/2011/10/03/infobaenobel.jpg", "https://www.blogger.com/profile/05824074357364364632", "https://farmanetwork.blogspot.com/2011/10/el-nobel-de-medicina-compartido-por-3.html?m=0#comment-form", "https://www.blogger.com/email-post.g?blogID=5620298639202866827&postID=1531051145923269944", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1531051145923269944&target=email", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1531051145923269944&target=blog", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1531051145923269944&target=twitter", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1531051145923269944&target=facebook", "https://www.blogger.com/share-post.g?blogID=5620298639202866827&postID=1531051145923269944&target=pinterest", "https://farmanetwork.blogspot.com/search/label/investigaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/salud?m=0", "https://farmanetwork.blogspot.com/search?updated-max=2012-04-27T20:48:00-04:30&max-results=7&reverse-paginate=true&m=0", "https://farmanetwork.blogspot.com/search?updated-max=2011-10-08T12:39:00-04:30&max-results=7&m=0", "https://farmanetwork.blogspot.com/?m=0", "https://farmanetwork.blogspot.com/2011/10/?m=1", "https://farmanetwork.blogspot.com/feeds/posts/default", "https://www.blogger.com/profile/05824074357364364632", "https://www.blogger.com/profile/05824074357364364632", "https://www.netvibes.com/subscribe.php?url=https%3A%2F%2Ffarmanetwork.blogspot.com%2Ffeeds%2Fposts%2Fdefault", "https://add.my.yahoo.com/content?url=https%3A%2F%2Ffarmanetwork.blogspot.com%2Ffeeds%2Fposts%2Fdefault", "https://farmanetwork.blogspot.com/feeds/posts/default", "https://www.netvibes.com/subscribe.php?url=https%3A%2F%2Ffarmanetwork.blogspot.com%2Ffeeds%2Fcomments%2Fdefault", "https://add.my.yahoo.com/content?url=https%3A%2F%2Ffarmanetwork.blogspot.com%2Ffeeds%2Fcomments%2Fdefault", "https://farmanetwork.blogspot.com/feeds/comments/default", "http://www.linkedin.com/groups?mostPopular=&gid=3696813", "http://visiondegiovanny.blogspot.com/", "http://gerenciavenezolana.blogspot.com/", "https://farmanetwork.blogspot.com/2011/09/descubren-un-interruptor-biologico-para.html?m=0", "https://farmanetwork.blogspot.com/2011/09/descubren-un-interruptor-biologico-para.html?m=0", "https://farmanetwork.blogspot.com/2013/04/modelos-de-farmacias-en-europa.html?m=0", "https://farmanetwork.blogspot.com/2013/04/modelos-de-farmacias-en-europa.html?m=0", "https://farmanetwork.blogspot.com/2013/01/los-genericos-pueden-romper-la.html?m=0", "https://farmanetwork.blogspot.com/2013/01/los-genericos-pueden-romper-la.html?m=0", "http://pinterest.com/giovannyleon/farma-network/", "https://farmanetwork.blogspot.com/search/label/industria%20farmac%C3%A9utica?m=0", "https://farmanetwork.blogspot.com/search/label/salud?m=0", "https://farmanetwork.blogspot.com/search/label/investigaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/tendencias?m=0", "https://farmanetwork.blogspot.com/search/label/mercado%20farmac%C3%A9utico?m=0", "https://farmanetwork.blogspot.com/search/label/estrategia?m=0", "https://farmanetwork.blogspot.com/search/label/tecnologia?m=0", "https://farmanetwork.blogspot.com/search/label/regulaci%C3%B3n%20farmac%C3%A9utica?m=0", "https://farmanetwork.blogspot.com/search/label/farmacia?m=0", "https://farmanetwork.blogspot.com/search/label/Ciencia?m=0", "https://farmanetwork.blogspot.com/search/label/marketing?m=0", "https://farmanetwork.blogspot.com/search/label/web2.0?m=0", "https://farmanetwork.blogspot.com/search/label/redes%20sociales?m=0", "https://farmanetwork.blogspot.com/search/label/Venezuela?m=0", "https://farmanetwork.blogspot.com/search/label/economia?m=0", "https://farmanetwork.blogspot.com/search/label/tecnolog%C3%ADa?m=0", "https://farmanetwork.blogspot.com/search/label/creatividad?m=0", "https://farmanetwork.blogspot.com/search/label/comunicacion?m=0", "https://farmanetwork.blogspot.com/search/label/etica%20laboral?m=0", "https://farmanetwork.blogspot.com/search/label/educaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/formaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/previsiones?m=0", "https://farmanetwork.blogspot.com/search/label/ventas?m=0", "https://farmanetwork.blogspot.com/search/label/branding?m=0", "https://farmanetwork.blogspot.com/search/label/mundo?m=0", "https://farmanetwork.blogspot.com/search/label/seguridad?m=0", "https://farmanetwork.blogspot.com/search/label/Tips%20gerenciales?m=0", "https://farmanetwork.blogspot.com/search/label/cultura?m=0", "https://farmanetwork.blogspot.com/search/label/negocios?m=0", "https://farmanetwork.blogspot.com/search/label/hijos?m=0", "https://farmanetwork.blogspot.com/search/label/investigacion?m=0", "https://farmanetwork.blogspot.com/search/label/medicamentos?m=0", "https://farmanetwork.blogspot.com/search/label/2013?m=0", "https://farmanetwork.blogspot.com/search/label/Farma?m=0", "https://farmanetwork.blogspot.com/search/label/RSE?m=0", "https://farmanetwork.blogspot.com/search/label/Web%202.0?m=0", "https://farmanetwork.blogspot.com/search/label/an%C3%A1lisis?m=0", "https://farmanetwork.blogspot.com/search/label/balance%20vida-trabajo?m=0", "https://farmanetwork.blogspot.com/search/label/carrera?m=0", "https://farmanetwork.blogspot.com/search/label/consolidaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/diversidad%20e%20inclusi%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/ecolog%C3%ADa?m=0", "https://farmanetwork.blogspot.com/search/label/ejercicio?m=0", "https://farmanetwork.blogspot.com/search/label/equipo?m=0", "https://farmanetwork.blogspot.com/search/label/formacion?m=0", "https://farmanetwork.blogspot.com/search/label/fusiones?m=0", "https://farmanetwork.blogspot.com/search/label/f%C3%A1rmacos?m=0", "https://farmanetwork.blogspot.com/search/label/genoma?m=0", "https://farmanetwork.blogspot.com/search/label/gen%C3%A9tica?m=0", "https://farmanetwork.blogspot.com/search/label/gerencia%20y%20l%C3%ADderazgo?m=0", "https://farmanetwork.blogspot.com/search/label/infografia?m=0", "https://farmanetwork.blogspot.com/search/label/innovaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/inspiracional?m=0", "https://farmanetwork.blogspot.com/search/label/inversiones?m=0", "https://farmanetwork.blogspot.com/search/label/negocios%202.0?m=0", "https://farmanetwork.blogspot.com/search/label/pharma?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2016/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2016/12/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2016/06/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2015/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2015/10/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2015/08/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2015/05/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2015/02/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2015/01/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/12/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/11/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/08/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/05/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/04/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2014/01/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/12/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/11/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/10/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/09/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/07/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/06/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/05/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/04/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/03/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/02/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2013/01/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/12/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/11/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/10/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/09/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/08/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/07/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/06/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/05/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/04/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/03/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2012/02/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/12/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/10/?m=0", "https://farmanetwork.blogspot.com/2011/10/las-farmaceuticas-navegan-en-la.html?m=0", "https://farmanetwork.blogspot.com/2011/10/el-nobel-de-medicina-compartido-por-3.html?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/09/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/08/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/07/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/05/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/04/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/02/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2011/01/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2010/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2010/12/?m=0", "javascript:void(0)", "https://farmanetwork.blogspot.com/2010/11/?m=0", "http://pinterest.com/giovannyleon/boards/", "https://farmanetwork.blogspot.com/search/label/2013?m=0", "https://farmanetwork.blogspot.com/search/label/an%C3%A1lisis?m=0", "https://farmanetwork.blogspot.com/search/label/balance%20vida-trabajo?m=0", "https://farmanetwork.blogspot.com/search/label/branding?m=0", "https://farmanetwork.blogspot.com/search/label/carrera?m=0", "https://farmanetwork.blogspot.com/search/label/Ciencia?m=0", "https://farmanetwork.blogspot.com/search/label/comunicacion?m=0", "https://farmanetwork.blogspot.com/search/label/consolidaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/creatividad?m=0", "https://farmanetwork.blogspot.com/search/label/cultura?m=0", "https://farmanetwork.blogspot.com/search/label/diversidad%20e%20inclusi%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/ecolog%C3%ADa?m=0", "https://farmanetwork.blogspot.com/search/label/economia?m=0", "https://farmanetwork.blogspot.com/search/label/educaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/ejercicio?m=0", "https://farmanetwork.blogspot.com/search/label/equipo?m=0", "https://farmanetwork.blogspot.com/search/label/estrategia?m=0", "https://farmanetwork.blogspot.com/search/label/etica%20laboral?m=0", "https://farmanetwork.blogspot.com/search/label/Farma?m=0", "https://farmanetwork.blogspot.com/search/label/farmacia?m=0", "https://farmanetwork.blogspot.com/search/label/f%C3%A1rmacos?m=0", "https://farmanetwork.blogspot.com/search/label/formacion?m=0", "https://farmanetwork.blogspot.com/search/label/formaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/fusiones?m=0", "https://farmanetwork.blogspot.com/search/label/gen%C3%A9tica?m=0", "https://farmanetwork.blogspot.com/search/label/genoma?m=0", "https://farmanetwork.blogspot.com/search/label/gerencia%20y%20l%C3%ADderazgo?m=0", "https://farmanetwork.blogspot.com/search/label/hijos?m=0", "https://farmanetwork.blogspot.com/search/label/industria%20farmac%C3%A9utica?m=0", "https://farmanetwork.blogspot.com/search/label/infografia?m=0", "https://farmanetwork.blogspot.com/search/label/innovaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/inspiracional?m=0", "https://farmanetwork.blogspot.com/search/label/inversiones?m=0", "https://farmanetwork.blogspot.com/search/label/investigacion?m=0", "https://farmanetwork.blogspot.com/search/label/investigaci%C3%B3n?m=0", "https://farmanetwork.blogspot.com/search/label/marketing?m=0", "https://farmanetwork.blogspot.com/search/label/medicamentos?m=0", "https://farmanetwork.blogspot.com/search/label/mercado%20farmac%C3%A9utico?m=0", "https://farmanetwork.blogspot.com/search/label/mundo?m=0", "https://farmanetwork.blogspot.com/search/label/negocios?m=0", "https://farmanetwork.blogspot.com/search/label/negocios%202.0?m=0", "https://farmanetwork.blogspot.com/search/label/pharma?m=0", "https://farmanetwork.blogspot.com/search/label/previsiones?m=0", "https://farmanetwork.blogspot.com/search/label/redes%20sociales?m=0", "https://farmanetwork.blogspot.com/search/label/regulaci%C3%B3n%20farmac%C3%A9utica?m=0", "https://farmanetwork.blogspot.com/search/label/RSE?m=0", "https://farmanetwork.blogspot.com/search/label/salud?m=0", "https://farmanetwork.blogspot.com/search/label/seguridad?m=0", "https://farmanetwork.blogspot.com/search/label/tecnologia?m=0", "https://farmanetwork.blogspot.com/search/label/tecnolog%C3%ADa?m=0", "https://farmanetwork.blogspot.com/search/label/tendencias?m=0", "https://farmanetwork.blogspot.com/search/label/Tips%20gerenciales?m=0", "https://farmanetwork.blogspot.com/search/label/Venezuela?m=0", "https://farmanetwork.blogspot.com/search/label/ventas?m=0", "https://farmanetwork.blogspot.com/search/label/Web%202.0?m=0", "https://farmanetwork.blogspot.com/search/label/web2.0?m=0", "http://www.slideshare.net/?src=multiwidget", "http://www.slideshare.net/widgets/playlist", "https://www.blogger.com"]}